SEC Form 4 research
| Issuer | Braveheart Bio, Inc. |
|---|---|
| Tickers | BRVE |
| Reporting owners | 23 |
| Officers and directors | 9 |
| Last public filing | 2026-08-12 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-11 | 2026-08-07 | AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Andreessen Marc L, HOROWITZ BENJAMIN A | P | 1,100,000 | $18 | Not reported |
| 2026-08-11 | 2026-08-07 | Chimovits Erez | P | 273,333 | $18 | Not reported |
| 2026-08-11 | 2026-08-07 | Chimovits Erez | P | 1,666,667 | $18 | Not reported |
| 2026-08-11 | 2026-08-07 | ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC | P | 273,333 | $18 | Not reported |
| 2026-08-11 | 2026-08-07 | ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC | P | 1,666,667 | $18 | Not reported |
| 2026-08-07 | 2026-08-07 | Rickey James Paul | P | 27,777 | $18 | Not reported |
| 2026-08-07 | 2026-08-05 | Rickey James Paul | A | 300,000 | $0 | Not reported |
| 2026-08-07 | 2026-08-05 | Lohoff Tim | A | 30,000 | $0 | Not reported |
| 2026-08-07 | 2026-08-05 | Chimovits Erez | A | 30,000 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Viehbacher Christopher | P | 83,333 | $18 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.